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Abstract 
 
Post-translational modification of protein is an important phenomenon in biology. Protein 
phosphorylation is one of post-translational modification and is responsible for signal transduction 
system and many kinds of cellular metabolisms. Especially, our research focused on histidine 
phosphorylation. 
Chapter 1 introduces the characteristics of histidine phosphorylation and the related research so far. 
Histidine phosphorylation is N-phosphorylation, which is the phosphorylation on N atom of imidazole 
to form P-N bond and has acid labile property. Histidine phosphorylation was observed in many 
biological events. The most famous histidine phosphorylation is two-component system (TCS), which 
is the fundamental signal transduction system in bacteria. Also, it was found in eukaryotes such as 
nucleoside diphosphate kinase (NDPK), protein phosphohistidine phosphatase 1 (PHPT1), histone H4 
and so on. However, because of its acid-labile chemical instability, there were insufficient tools for 
studying histidine phosphorylation and histidine phosphorylation was rarely explored. Currently 
available tools for phosphohistidine are radiolabeling analysis and antibody detection, which are not 
suitable for continuous enzyme assays. So we try to develop new tool for phosphohistidine, continuous 
and available for kinetic assay. 
Chapter 2 describes our main research subject and progress. We devised Sox-based fluorescence sensor 
for phosphohistidine, which was basically a short peptide having kinase recognition domain, 
phosphorylation site (histidine) and Sox fluorophore. When histidine was phosphorylated, histidine 
phosphate group and Sox fluorophore chelated with magnesium cation and increased fluorescence by 
chelation-enhanced fluorescence (CHEF) effect, while no fluorescence when histidine was not 
phosphorylated. We designed simple peptide sensors, and then they were chemically phosphorylated 
and evaluated for their feasibility as phosphohistidine sensors. 
In chapter 3, we briefly describe the protein labeling strategy using isotope-labeled desthiobiotin tags 
by APEX system. Especially, we synthesized a series of isotope-labeled desthiobiotinyl tyramine tags 
through enzymatic decarboxylation and acid coupling reaction. 
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Chapter 1. Introduction – Chemical Tools for Histidine Phosphorylation 
 
1.1 Protein Phosphorylation 
 
Proteins have important roles in living organisms. In vivo, they are synthesized from DNAs 
through several steps; DNAs (Deoxyribonucleic acids) are first transcribed into complementary 
mRNAs (messenger Ribonucleic acids), and proteins are synthesized from the mRNAs via 
translation. After proteins are synthesized, they can be covalently modified, and such phenomenon 
is called post-translational modification (PTM). 
 
  
Figure 1-1. Post-translational modification 
 
Protein phosphorylation1,2) is an important PTM in biology; proteins are phosphorylated by 
protein kinases using ATP as a phosphate donor; the ATP is converted into ADP and one phosphate 
group is attached on the protein. The phosphorylation events can lead to the modulation of 
enzymatic activities or the association with other proteins on the phosphorylated residues in a 
sequence-specific manner. Also, the phosphate group on the phosphorylated proteins can be 
transferred to another proteins and signal is transduced. Hence, study of protein phosphorylation 
will be helpful for understanding of cellular functions and metabolisms. 
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1.2 Protein Histidine Phosphorylation 
 
Among 20 kinds of amino acids, protein phosphorylation on serine, threonine and tyrosine 
residues are best known. However, histidine, lysine or arginine phosphorylation has been long 
known but they have been much less explored because of their chemical instability.3,4) 
 
   
Figure 1-2. Protein phosphorylation on residues 
 
Compared with phosphoserine (pSer), phosphothreonine (pThr) and phosphotyrosine (pTyr), 
phosphohistidine (pHis) has low stability since N-P bond has higher energy than O-P bond. ΔG of 
hydrolysis of pHis is -12 to 13 kcal/mol whereas hydroxyamino acids have -6.5 to -9.5 kcal/mol. 
pHis has acidic-labile characteristics; nitrogen in phosphohistidine can be easily protonated than 
oxygen in pSer, pTyr and pThr phosphoester, and the imidazole group can be a good leaving group 
for the hydrolysis of the N-P bond 
 
1.3 Biological Function of Protein Histidine Phosphorylation 
 
1.3.1 Two-component System (TCS)5) 
Phosphorylation of histidine residues is well known in so-called two-component signal 
transduction systems (TCSs), which are important signaling systems in prokaryotes, as well as 
in plants and fungi. TCSs consist of histidine kinases (HKs) and response regulators (RRs). 
Basically, histidine kinases are receptor-like proteins on bacterial cellular membrane and bear 
sensor domains on the extracellular side. When sensor domains are stimulated, histidine kinases 
undergo conformational changes and its catalytic kinase domain (CA domain) gets activated, 
which then autophosphorylates a histidine residue of the dimerization domain (DHp domain). 
One example of histidine kinase is CheA involved in bacterial chemotaxis. CheA exists in 
intracellular cytoplasm not in cellular membrane. It does not bear a sensor domain, but interacts 
with the cytoplasmic domains of many chemoreceptors. 
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The phosphoryl group on the pHis of the HK then gets transferred to an Asp residue of a 
receiver domain in RR protein, and signaling process is continued. The phosphorylated of RR 
induces a conformational change of effector domain, to bind into DNA and control transcription 
process or to activate its own enzymatic activity for downstream signaling transduction. 
 
1.3.2 Phosphohistidine Phosphatase in TCSs6) 
Along with the studies of His kinases, studies of phosphohistidine phosphatases have been 
carried out. An E. coli phosphohistidine phosphatase that specifically catalyzes the 
dephosphorylation of pHis717 in HPt domain of ArcB, which is a histidine kinase of TCS, was 
investigated and designated as signal inhibitory factor-X (SixA). SixA is a 17.2 kDa protein 
which has two histidine residues, His8 and His108, and His8, included in arginine-histidine-
glycine (RHG) motif, is crucial for enzymatic ability demonstrated by the loss of function from 
the mutant protein lacking His8. When His717 in HPt is phosphorylated, phosphohistidine 
becomes a phosphate donor for the OmpR response regulator, which is a transcriptional 
regulator in the osmoregulation of porin composition of the E. coli outer membrane. Hence, 
SixA works as a modulator in phosphorelay system of prokaryotes. 
 
1.3.3 Nucleoside Diphosphate Kinase (NDPK) in Eukaryotes 
There have been a number of studies focusing on protein histidine phosphorylation in 
mammalian cells. So far, the best known protein histidine kinases are two isoforms of NDPK 
(Nucleoside Diphosphate Kinase); NDPK-A (Nm23H1)7) and NDPK-B (NM23H2)8,9). NDPK-
A has been reported to phosphorylate annexin 1 on a histidine residue10,11) and NDPK-B is 
responsible for the His phosphorylation in KCa3.1 potassium channel and its activation.9,12) 
Also, NDPK-B phosphorylates His266 in the β-subunit (Gβ) of trimeric G-proteins and helps the 
activation of Gs by transferring the phosphoryl group to GDP and forming GTP which binds to 
alpha-subunit of Gs and activates it.8,13) 
With maintaining NDP/NTP levels, NDPK transfers phosphoryl groups from NTP to NDP 
through autophosphorylation of a His residue in its active site (His118 in human NDPK).14) Yet, 
it is unclear how it can phosphorylate histidine residues in other proteins. 
 
1.3.4 Ca2+-activated K+ Channel KCa3.1 
The Ca2+-activated K+ Channel KCa3.1, which is composed of 370 amino acids, is 
responsible for the influx of Ca2+, which leads to the activation of T cells and B cells.9,15) KCa3.1 
was found in blood cells, epithelia, and smooth muscle cells, and its function is the replacement 
of cytosolic Ca2+ into K+ and thereby it controls the membrane potential to balance with K+ 
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equilibrium potential.16-19) This change of membrane potential can affect various physiological 
responses in many types of cells, such as mitogen activation of T-lymphocytes, and regulation 
of cell volume in erythrocytes, Cl- secretion in exocrine epithelial cells and proliferation of T 
and B cells, vascular smooth muscle cells and keratinocytes.20-27) Pharmacological targeting of 
KCa3.1 channel is expected to have effects in proliferative diseases and autoimmune diseases, 
such as restenosis, transplant rejection, secretory diarrheas, sickle cell anemia, cystic fibrosis, 
etc.17,18,25,28) Comparing with its homologues, KCa3.1 has a unique sequence of 14 amino acids 
on C-terminus and this sequence has a binding affinity to NDPK-B. In fact, NDPK-B 
phosphorylates KCa3.1 at His358 with regulation by phosphatidylinositol 3 phosphate (PI(3)P) 
and the phosphorylation event activates KCa3.1. 
 
1.3.5 Histone H4 
Histones are DNA-binding proteins in the nucleus. Compared with other proteins, they 
have lots of arginine, lysine and histidine amino acids, which are positively charged in 
physiological conditions around pH 7. As DNA is negatively charged, histones with positive 
charges electrostatically bind to DNA. In regenerating rat liver cells, it was found that two 
kinases catalyzed phosphorylation to form acid-labile and alkali-stable protein phosphates on 
histone H1 and H4, and it was subsequently confirmed as pHis in histone H4 whereas 
phospholysine in histone H1.29,30) Histone H4 contains two histidine residue sites, His18 and 
His75. Yet, it is unclear which position is phosphorylated by histone histidine kinases, and the 
specific histone histidine kinases are still remained elusive. The biological effect of histidine 
phosphorylation on histone is not fully demonstrated, but it is expected to regulate gene 
activation, DNA replication or mitosis 
 
1.3.6 Summary of Known Phosphohistidine Proteins in Biology 
 
  Roles Proteins 
Intermediate of 
enzymes in 
phosphotransfer 
to other 
components 
Nucleoside diphosphate kinase (NDPK)31,32), ATP-citrate lyase33), 
Glucose-6-phosphate34), 6-Phosphofructo-2-kinase35), 
Phosphoglycerate mutase36,37), Phospholipase D38), Prostatic acid 
phosphatase39), Succinyl-CoA synthetase40) 
Substrates of 
histidine kinases 
Annexin I10), ATP-citrate lyase41), Heterotrimeric G protein8,42,43,44), 
Histone H430,45,46), KCa3.1 potassium channel9,15), Thymidylate 
synthase47) 
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Histidine 
Kinases 
Two-component signaling pathways48,49,50,51) , NDPK8,9,41), Histone 
H4 histidine kinase29,52,53,54,55) 
Phosphohistidine 
Phosphatases 
 PHPT156,57,58), Protein phosphatase 1A, 2A, and 2C59,60) 
 
 
1.4 Methods for Studying Phosphohistidine 
 
1.4.1 Preparation of Phosphohistidine61) 
Phosphohistidine can be prepared chemically using potassium phosphoramidate (PPA) at 
pH 7. Phosphohistidine-containing polypeptides can be prepared by PPA-mediated chemical 
phosphorylation. Potassium phosphoramidate does not phosphorylate any other amino acid 
residues at neutral pH. For protein autophosphorylation, bacterial histidine kinases and ATP can 
be utilized. 
 
1.4.2 Detection - Isotope-labeling 32P and Amino Acid Analysis62,63) 
Conventional method for protein quantity was an amino acid analysis. Generally, protein 
of interest was hydrolyzed by strong acid at high temperature (such as, 6M HCl, 110 OC, 24 
hours). The POI was hydrolyzed into single amino acids and these were analyzed quantitatively 
by HPLC or electrophoresis. In case of phosphohistidine proteins, however, acid hydrolysis 
was not suitable since phosphohistidine is acid-labile and base-stable. Thus, base hydrolysis 
was adopted, of which condition was under 3M KOH at 105 OC for 3 hours. 
[γ-32P]ATP was generally used to make isotope-labeled phosphoproteins and useful for 
protein kinase assay. POI was incubated with [γ-32P]ATP and its kinase with appropriate 
physiological condition. Phosphoimage in electrophoresis or radioactivity test easily defined 
isotope-labeled phosphoproteins. 
On the other hand, phosphorylation could occur on histidine as well as on serine, threonine 
and tyrosine residues. While pTyr is are stable both in acid and base, pSer and pThr are unstable 
under basic conditions. Since pHis is stable in base but labile in acid, it can be indirectly 
distinguished from pSer, pThr, or pTyr by acid/base treatment. 
 
1.4.3 Detection - Mass Spectrometry64) 
    Mass spectrometry (MS) analysis is fundamental in many of chemistry research. There 
have been few reports of using MS analysis for detection of pHis proteins because of its acid-
lability. Synthetic pHis-peptide was analyzed by matrix-associated laser desorption ionization 
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(MALDI)-high-energy collision-induced dissociation (CID) MS and electrospray ionization 
(ESI) MS. For example, histone H4 was phosphorylated chemically using potassium 
phosphoramidate, and two histidine residues were phosphorylated. Then, it was digested by 
trypsin or endoproteinase Asp-N and two different pHis-containing fragments were detected.  
 
1.4.4 Detection - Antibodies and Western Blots65,66) 
Antibodies have specific and strong interactions with their respective antigens and are 
utilized in specific detection and quantification method such as ELISA and western blots. 
Generally, an immunogen gets injected into animals such as rabbits and mice and the antibodies 
against the immunogen are generated. Then, serum from the animals is affinity-purified to 
provide the desired antibodies. In case of small antigens, they are conjugated with carrier 
proteins which are immunogenic, called haptens, and the conjugated materials are injected. 
However, the generation of pHis-specific antibodies was extremely challenging because pHis 
was not stable immunization in vivo. To address this challenge, stable synthetic pHis analogues 
were designed and prepared by Kee et. al. and it was successfully employed to generate anti-
pHis antibodies. 
   These antibodies marked an important milestone in pHis research, since they enabled 
specific detection and quantification of pHis proteins. Using these antibodies, novel pHis 
proteins from E. coli have been discovered and enzymatic phosphorylation assays were 
successfully carried out.  
 
1.5 Conclusion and Future perspectives 
 
Protein phosphorylation is one of important event above post-translational modification. 
Histidine phosphorylation was first observed over 50 years ago, but its research lagged behind 
compared with serine/threonine/tyrosine phosphorylation because of the acid-lability and lack of 
detection tools of phosphohistidine. There have been many attempts to devise detection method for 
phosphohistidine, but simple and real time methods for measuring pHis levels are required. In 
Chapter 2, we will describe our progress on the development of fluorescence-based chemical probes 
for real-time measurement of histidine kinases and pHis phosphatase enzyme activities. 
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Chapter 2. Sox-Based Fluorescence Sensor for Phosphohistidine 
 
2.1 Introduction 
 
2.1.1 Need for Fluorescence-based Protein Phosphorylation Sensors 
Intracellular phosphorylation is accomplished by enzymatic function of protein kinase 
against extracellular stimuli.1-4) Phosphorylation has an important role in cellular metabolism 
as well as intercellular communication in eukaryotes.5) Protein kinase superfamily accounts for 
approximately 2 % of the human genome and includes 500 kinases.2) Protein kinases catalyze 
transferring of the γ-phosphoryl group from adenosine-5-triphosphate (ATP) to free a hydroxyl, 
amino, or imidazole group in the target peptide or protein10,11). For the operation of kinases, 
divalent metal ions6-9), most commonly Mg2+, are necessary as they activate the ATP and there 
are other many factors controlling the activity of kinases such as its phosphorylation state, 
subcellular localization or binding interactions within protein complexes.24,25) Since protein 
kinase has a critical role and its malfunction results in severe diseases12-16), protein kinase 
regulation has been of high interest and become a major therapeutic targets over past decades17). 
Indeed, many pharmaceutical and biotechnology companies have focused on the development 
of protein kinase inhibitors. Hence, specific and sensitive tools to measure the target kinase 
activities are essential in study of drug discoveries as well as signaling mechanisms18-23). 
A commonly used assay for protein kinase activity is a radioactivity-based assay in which 
phosphoryl group transfer from [γ-32P]ATP to a peptide or protein substrate is quantified by 
scintillation counting. This method is discontinuous and requires the enzymatic reaction of 
kinase to be stopped for the subsequent processing steps. Thus, it does not provide direct 
kinetic information, requires special handling and generates radioactive waste. In addition, [γ-
32P]ATP is used for all kinases, so it is not applicable to simultaneous measurement of multiple 
kinases. Another phosphorylation detection method is using specific antibodies directly 
against phosphorylated residues, but it also needs post-reaction processing steps such as 
ELISA and Western blots after cell lysis.  
Recently, fluorescence spectroscopy has been rising as a beneficial tool and become a 
major research tool in biological research because of its high sensitivity (up to a 1000-fold 
higher than absorption spectrometry), selectivity, experimental simplicity, short detection time 
and compatibility with standard instrumentation. Compared with traditional assays, 
fluorescence spectroscopy is applicable to continuous assays and gives an excellent spatial and 
temporal resolution in cellulo as well as observation of kinase activity in real time measurement. 
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2.1.2 Design and Strategy for CHEF-based Phosphorylation Sensors  
 
To accomplish facile continuous and real-time histidine kinase activity, we chose 
Sox-based fluorescence chemosensors, which are peptide-based kinase substrates comprising 
non-natural Sox fluorophore26,27). As most kinases have their specific substrates, the peptide 
sequence is mimicked from the known substrate of the kinase of interest (KOI). By changing 
the kinase substrate sequence, various kinase sensors specific for each KOI can be prepared. 
Sox is the fluorophore 8-hydroxy-5-(N,N-dimethylsulfamoyl)-2-methylquinoline, which 
exhibits chelation-enhanced fluorescence (CHEF) by divalent metal ions. Sox was firstly 
devised for sensing divalent metal ions, especially for Zn2+ ion because of high chelation 
binding between Zn2+ ion and Sox molecule. Mg2+ ion shows weaker chelation binding than 
Zn2+ ion, but this mild binding makes it possible to apply Sox fluorophore in protein kinase 
sensor. When the peptide sensor is phosphorylated, the phosphoryl group assists Mg2+ ion to 
chelate Sox molecule. Sox molecule then shows increased fluorescence by CHEF effect. 
Accordingly, the fluorescence of the Sox molecule can tell us whether the peptide sensor is 
phosphorylated or not under same Mg2+ ion concentration and it is highly suitable as kinase 
chemosensor. 
 
 
Figure 2-1. Kinase sensor for serine phosphorylation. (Shults et. al., Nat. Meth. 2005)33) 
 
Shults et. al.30) reported Sox-based peptide chemosensor of the kinase for hydroxyl 
group (serine/threonine/tyrosine) phosphorylation. However, Sox-based peptide chemosensor 
has not been applied into histidine phosphorylation. Since there was no real time assay for 
histidine phosphorylation, we designed Sox-based peptide chemosensor for histidine 
phosphorylation. 
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Figure 2-2. Design and Strategy for the kinase sensor for phosphohistidine 
 
Previously, the peptide substrate was prepared using non-natural amino acid Fmoc-Sox-
OH29,30) via Solid Phase Peptide Synthesis (SPPS). Instead of non-natural amino acid, we used 
cysteine and it was reacted with Sox-halide to accomplish cysteine derivative of Sox 
fluorophore termed as CSox27,31,32). 
 
 
 
 
Figure 2-3. Two different approaches for Sox-contained kinase sensor;  
1) Non-natural amino acid, Fmoc-Sox-OH and SPPS (up) and 
2) Sox-Br and alkylation on Cysteine (down) 
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2.2 Result and Discussion 
 
2.2.1 Preparation of Sox-Br  
    For cysteine modification, Sox bromide (Sox-Br, 7) was synthesized following the methods 
by Imperiali’s group with some improvements. In particular, Imperiali’s group made Sox-Br (7) 
from compound 4 (3 steps) without chromatographic purification. However, we tried purification 
in each step; compound 5 was unable because of the high reactivity of aldehyde group, but 
compound 6 was isolated clean. In the step of Sox-Br (7) synthesis, N-bromosuccinimide (NBS) 
and triphenylphosphine were pre-mixed in dichloromethane and added dropwise into the perfectly 
dried compound 6. To increase the reaction rate, we used the amount of NBS and 
triphenylphosphine as 5 molar equivalents against compound (6), and reaction time was decreased 
but the yield was moderate. 
 
 
 
 
Scheme 2-1. Synthesis of Sox-Br 
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2.2.2 Design of Model substrate 
 
 
Scheme 2-2. Synthesis of Model Substrate 
 
    A model substrate (10), mimicking cysteine-histidine dipeptide, was synthesized to confirm 
whether 1) cysteine modification to construct CSox and phosphorylation of histidine-mimic 
imidazole were possible and 2) fluorescence was different after phosphorylation. 
 
  
 
 
Scheme 2-3. Synthesis of Model kinase sensor (12) and Phosphorylation (13) 
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The model substrate (10) was alkylated with Sox-Br on the thiol to afford the model kinase 
sensor (12). It was then phosphorylated with PPA under Mg2+ and the fluorescence change was 
observed. 
 
 
 
 
Scheme 2-4. Other Two Model Substrates for Linker Optimization 
 
Also, two kinds of model substrates (18 and 22) were prepared to identify the length effect 
between CSox and Phosphorylimidazole in three-dimensional structure. To extend the length, we 
used a glycine linker. 
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Scheme 2-5. Linker-Dependent Fluorescence Difference 
 
Before designing the substrate sensors specific for KOI, simple model substrates were 
designed, synthesized and tested whether Sox and phosphorylation on histidine successfully 
emitted increased fluorescence. 
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Figure 2-4. Design of the model substrates 
 
Model substrates were targeted to short peptides which were parts of the substrate sensors of 
KOI. They should contain a cysteine to reacts with Sox-Br to form CSox and a histidine for pHis 
formation. Simplest model substrate was cysteine-histidine dipeptide. Generally, reactions with 
amino acids were hard to apply in solution phase reaction. Rather, they usually adopted Solid Phase 
Peptide Synthesis (SPPS). We tried to make model substrates in solution phase, and chose Cys-His 
dipeptide mimicked model substrate, which was the ligation of mercaptopropionic acid (MPA) and 
histamine [n+1]. This model substrate contained necessary residue groups, which were the thiol 
from cysteine and imidazole from histidine and discarded unnecessary parts. 
On the other hand, three-dimensional distance was considered, and a glycine or a couple of 
glycine was inserted between MPA and histamine [n+2 and n+3].  
 
2.2.3 Preparation of Model Substrates 
 
 
Scheme 2-6. Coupling of histamine and 3-mercaptopropionic acid (failed) 
 
We began with the carboxylic acid coupling reaction between histamine and 3-
mercaptoproponic acid (MPA). There are many kinds of commercially available coupling reagents 
activating carboxylic acids such as N,N’-dicyclohexylcarbodiimide (DCC), 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexaﬂuorophosphate). We tried to use DCC, but the byproduct N,N’-
dicyclohexylurea (DCU) from DCC was hard to remove after the reaction. 
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Scheme 2-7. Coupling of histamine and 3-mercaptopropionic acid using DCC/NHS chemistry 
 
As DCC had relatively slow reactivity, we adapted DCC/NHS chemistry and divided the 
reaction into two steps. Interestingly, DCU is slightly soluble in hexane, dichloromethane, ethyl 
acetate or N,N-dimethylformamide and well-soluble in alcohols, but rarely soluble in acetonitrile. 
Using acetonitrile solvent, DCU was easily removed and the product was obtained quite pure. 
However, the final product was not obtained. According to the previous trials, controlling thiol 
group was much important than other factors, and we decided to protect free thiol group at first 
using trityl (triphenylmethyl) chloride. 
 
 
Scheme 2-8. Coupling of histamine and trt-protected 3-mercaptopropionic acid 
 
Trityl protection was easily applied in 3-mercaptopropionic acid, and 3-tritylthiopropionic acid 
(8) was reacted with histamine. The product (9) was purified and confirmed by NMR. Using a base 
potassium carbonate, yield was lower than 20% and the reason was that histamine commercial 
source was di-hydrochloride salt form (histamine-2HCl) and the water formation between 
hydrochloric acid and potassium carbonate, which is an obstacle to DCC reactivity. Changing the 
base to triethylamine, yield was improved up to 70% with good purity. 
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Figure 2-5. Possible side reaction and HA breakage test 
 
Histamine has a primary amine as well as secondary amines, which are less reactive, but also 
possible to react with DCC-activated ester to form acyl imidazole. It was confirmed that strong 
nucleophile such as hydroxylamine was added and it may break acyl imidazole since imidazole is 
a good leaving group, whereas stable amide is unaffected. 
 
 
Scheme 2-9. Trityl deprotection 
 
Trityl deprotection was successfully achieved by treating trifluoroacetic acid (TFA). Reaction 
was very fast and ended up within a couple of minutes. Then the reaction solvent (DCM) and TFA 
were removed by rotary evaporator. The remained residue which was the mixture of white solid 
and oil-like liquid was washed by hexane. The white solid, triphenylmethane, was dissolved in 
hexane and removed and the liquid, desired product, was not mixed with hexane and made a layer 
beneath hexane layer. The hexane was removed by pipet suction carefully and hexane wash was 
repeated several times. 
  
23 
 
2.2.4 Preparation of Model Kinase Sensor 
 
  
Scheme 2-10. Sox-alkylation 
 
Now that the model substrate (10) and Sox-Br (7) were prepared, thiol alkylation was executed 
and model kinase sensor [n+1] (11) was prepared. But it was hard to get pure product using column 
chromatography, as the product trailed on TLC. Eventually, we purified the product by High-
Performance Liquide Chromatography (HPLC, 100% solvent A (clean H2O) to 30% solvent A (H2O) 
and 70% solvent B (9:1 of MeCN and H2O) in 15 minutes, TR=13.1 min.), and obtained the pure 
product. Theoretically, however, the product should be compound 11, but obtained product was 
compound 12. 
 
 
Scheme 2-11. Preparation of Model kinase sensor 
 
Actually, we saved one step for the final product, but still do not fully understand why TBDPS 
protecting group was removed during Sox-alkylation. Yield of compound 12 was 30% over 2 steps. 
Later, my colleague tested the stability of Sox-Br in various base species; Sox-Br was degraded 
fast on TMG, but moderately stable in DIPEA; Sox-Br was degraded in 1 hour by TMG, but it was 
durable in 18 hours in DIPEA. I followed the method of Imperiali’s group and insisted to use TMG 
for fast reaction, but DIPEA would be more proper base. 
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2.2.5 Linker Optimization of Model Kinase Sensors  
 
A glycine linker was used to control the distance between Sox fluorophore and target histidine 
residue. We designed cysteine-glycine-histidine (Cys-Gly-His) and cysteine-glycine-glycine-
histidine (Cys-Gly-Gly-His) mimics, that is, MPA-Gly-Histamine and MPA-Gly-Gly-Histamine. 
 
 
Scheme 2-12. Preparation of linker dependent substrates 
 
Our initial synthesis was C-terminus to N-terminus synthesis; which means that Boc-glycine 
was ligated with histamine, Boc group was deprotected and the free amine of N-terminus on glycine 
was ligated with 3-tritylthiopropionic acid. This reaction scheme is similar with that of SPPS 
method. Also coupling reagent was changed from DCC to HBTU. Actually, however, it was failed 
to obtain compound 17 (trt-MPA-gly-histamine) because compound 16 (gly-histamine) and 17 had 
similar chemical properties such as polarity and mobility and it was impossible to separate them 
using chromatographic tools. 
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Scheme 2-13. Another approach to prepare linker dependent substrates 
 
So, we detoured synthetic design; instead of protecting N-terminus, C-terminus carboxylic acid 
was protected, and synthetic direction was N-terminus to C-terminus. As a result, we succeeded to 
obtain model substrate [n+2] (16), whereas model substrate [n+3] (22) was failed. It was kind of 
limitation of amino acid synthesis in solution method. Accordingly, we decided to apply SPPS methods 
and the tetrapeptides model kinase sensor [n+3] was synthesized 
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Scheme 2-14. SPPS method for preparation of model substrates 
 
SPPS method is an easy way to synthesize peptides, but it requires and consumes large amount 
of reagents and yield was low. Rather, in solution synthesis uses less amount of reagents than SPPS 
method, but the reactions using amino acid were hard to apply in solution synthesis. 
For fast progress, all model kinase sensors [n+1, n+2 and n+3] were prepared by SPPS 
methods. 
 
 
Scheme 2-15. Sox alkylation on resin strategies 
 
When the model substrates were synthesized by SPPS method, they were not cleaved from the 
resin and Sox-alkylation on thiol group was executed. This on-resin alkylation was advantageous 
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for the product isolation since the reagents and unnecessary chemicals were easily removed and 
flushed away and the product was stably cleaved from the resin. Peptide cleavage from the resin 
requires 95% TFA, while trityl group deprotection needs to 5% TFA. Thus, Trityl group was 
selectively removed without affecting to resin and free thiol was selectively alkylated with Sox 
fluorophore. 
 
2.2.6  Fluorescence Assay and Phosphorylation Test of Model Kinase Sensors 
 
 
Scheme 2-16. Phosphorylation of model kinase sensor [n+1] 
 
Since the model kinase sensor [n+1] was ready, chemical phosphorylation was carried out 
using potassium phosphoramidate (PPA). In our strategy, imidazole group should be 
phosphorylated and if magnesium ion existed, fluorescence intensity would be increased. To verify 
it, fluorescence assays were measured by Tecan (the fluorescence spectrometer). In 96-well corning 
black plate, sensor molecule stock solution (dissolved in methanol), magnesium stock solution 
(dissolved in water) and PPA stock solution (dissolved in water) were diluted in distilled water (in 
200 μL of total volume). Fluorescence was measured at 360 nm excitation and 485 nm emission.  
 
 
Figure 2-6. TLC monitoring of model kinase sensor phosphorylation (306 nm UV exposure) 
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At first, we checked TLC whether it could distinguish the reactant and product. Reactant, the 
unphosphorylated model sensor, showed very low Rf value (about 0.2) and streaked from the base 
point, whereas the reacted product (expected to the phosphorylated product) resulted in higher Rf 
value (about 0.4) when reacted for 6 hours in distilled water.  
 
 
Figure 2-7. UV exposure on 96-well black plate and observation of fluorescence by naked eye. 
 
This assay also can be visualized in naked eye by direct UV exposure (304 nm) on the 96-well 
plate in dark room. The sensor molecule itself did not show the fluorescence regardless of 
phosphorylation in the absence of Mg2+. Fortunately, the phosphorylated sensor molecule (the 
sensor molecule + PPA) released strong intensity of fluorescence when incubated with 10 mM 
Mg2+. 
 
 
Figure 2-8. Fluorescence assay of model kinase sensor; 1) distilled water (control); 2) 1 mM 
sensor molecule; 3) 1mM sensor molecule and 10 mM MgCl2; 4) 1mM sensor molecule and 100 
mM PPA; 5) 1mM sensor molecule, 100 mM PPA and 10mM MgCl2. 
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The fluorescence of sensor molecule itself was weak no matter whether it was phosphorylated 
or not, and CHEF by magnesium ion showed increased fluorescence for both phosphorylated and 
unphosphorylated sensors. However, the phosphorylated sensor with Mg2+ ion exhibited a little 
stronger fluorescence than the unphosphorylated sensor, although the difference was not significant. 
However, it was expected that optimization of the reaction condition such as changing the ratio and 
concentration of the sensor molecule and magnesium ion may improve the application of histidine 
phosphorylation sensor. 
 
 
Figure 2-9. Fluorescence change by sensor molecule concentration 
 
First, the sensor molecule was tested the linear relationship between the concentration and 
fluorescence. Also, magnesium ion concentration was changed and fluorescence was measured to 
find Kd for Mg2+ and the maximum fluorescence for the unphosphoryated sensor. MgCl2 
concentration was increased up to 1500 mM, but fluorescence was over the measurable range of 
equipment from the 1000 mM MgCl2. 
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Figure 2-10. The fluorescence change in dependence of magnesium ion. X-axis: the 
concentration of magnesium ion (mM) in 1mM unphosphorylated sensor molecule [n+1] 
molecule. 
 
Next, the sensor molecule was tested at 100 µM and the Mg2+ concentration was 10 mM and 
phosphorylation reaction was for 30 minutes with 10 mM PPA under pH 7.5 phosphate buffer. The 
result was consistent with previous data and the difference of fluorescence between phosphorylated 
sensor and non-phosphorylated sensor was definitely distinguished.  
 
 
 
Figure 2-11. Phosphorylation and fluorescence of the 100 µM sensor molecule with 10 mM 
MgCl2. pH 7.5 100 mM phosphate buffer 
 
To verify that the increase of fluorescence was due to the phosphorylation and CHEF effect 
and phosphorylation was successful, we tried to analyze the product using NMR, but it was 
unsuccessful due to small scale, insufficient amount for NMR detection. Instead, we carried out 
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indirect tests; it is well-known that phosphohistidine is quite stable under mild basic condition but 
unstable under acidic condition. We added concentrated HCl into the phosphorylated sensor 
molecule and fluorescence was quenched. Actually, at low pH, the nitrogen on quinoline of Sox 
fluorophore became protonated and the fluorescence was totally quenched. When the pH was 
adjusted back to pH 7.5, the fluorescence intensity remained much lower than the original 
phosphorylate sensor, indicating the pHis decomposition under acid led to fluorescence decrease. 
 
 
Figure 2-12. Dephosphorylation test by acid treatment. 
 
 
2.2.7  Future Direction: Preparation of the Substrates for Histidine kinases 
 
Since we tested the possibilities of the increase of fluorescence by Sox fluorophore via 
chelation of magnesium cation with phosphorylated imidazole of histidine or histidine mimics, we 
decided to synthesize the substrate for histidine kinase. We chose histone H4 protein and its kinase 
for our study. It is known that histone H4 has two positions for histidine phosphorylation (His18 
and His75) and we chose one position, His18. The sequence around His18 is GGAKRHRKVL. 
Generally, the enzyme-specific recognition sites for kinase substrates are a few amino acids, So, 
we set the 10 amino acid sequences as a base for sensor peptides. As we do not know the optimal 
position of Sox in the substrate for kinase reaction, we planned six sensor peptides for the test. 
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Scheme 2-17. Design of histone H4-mutated fragments 
 
Six kinds of sensor peptides will verify which position is most suitable for the control of 
distance between the phosphate group in phosphohistidine and Sox fluorophore, formed by 
cysteine alkylation with Sox halide. Then, comparing the phosphorylation between [n+α] and [n- 
α] positions’ sensor peptides, we will determine which residue should be mutated into cysteine; if 
the enzyme-recognition site is changed into cysteine with Sox alkylated, it might not function as 
the enzyme-recognition site and the enzyme-mediated phosphorylation can be difficult.  
 
 
Figure 2-13. Application of Sox-based kinase sensor; inhibitor screening 
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2.3 Conclusion 
 
   Histidine phosphorylation has been already known, even earlier than tyrosine, but it was not 
explored well because of the lack of tools for studying phosphohistidine. Sox fluorophore had been 
applied in serine, tyrosine, or threonine (O-phosphorylation)-containing proteins and measured 
their kinase activity, but it had not been applied in histidine or arginine (N-phosphorylation). 
Therefore, we introduced Sox fluorophore into histidine-containing model substrates and 
demonstrated the feasibility to evaluate histidine kinase activity using fluorescence measurement. 
Sox-based histidine kinase sensor will offer a new method for quick and real-time assays of 
histidine phosphorylation and dephosphorylation, and it will be a significant growth for the 
phosphohistidine research. 
 
2.4 Methods 
 
8-hydroxy-2-methylquinoline-5-sulfonyl chloride (2) 
8-hydroxy-2-methylquinole (1, 0.5 g, 3.14 mmol, purchased from Alfa Aesar) was dissolved in 
chlorosulfonic acid (2.5 ml, 37.6 mmol, purchased from Sigma Aldrich) and stirred at 25 OC for 2 
hours. The reaction mixture was added to a separatory funnel containing a slurry of ice in brine 
(125 mL) and dichloromethane (125 mL). The separatory funnel was shaken briefly and the 
dichloromethane layer was run into a flask with potassium carbonate. The resulting solution was 
filtered and evaporated and the resulting yellow product was obtained. (0.541 g, 2.11 mmol, 67 %) 
The obtained product was used in next reaction without further purification.  
TLC Rf = 0.63 (silica, CHCl3/MeOH, 4:1) Rf = 0.39 (silica, ethyl acetate) 
1H NMR (400 MHz, Chloroform-d) δ 8.97 (d, J = 8.8 Hz, 1H), 8.30 (d, J = 8.5 Hz, 1H), 7.63 (d, J 
= 8.8 Hz, 1H), 7.19 (d, J = 8.5 Hz, 1H), 2.81 (s, 3H). 
 
5-(N,N-dimethyl)sulfamoyl-8-hydroxy-2-methylquinoline (3) 
2M Dimethylamine in tetrahydrofuran (3.5 mL, 7 mmol, purchased from Alfa Aesar) was added 
under nitrogen to tetrahydrofuran (150 mL). 8-Hydroxy-2-methylquinoline-5-sulfonyl chloride (2, 
322 mg, 1.25 mmol) was added in small portions over 3 hours (about 10 mg per addition in every 
4 minutes) at room temperature. The solution was incubated for an additional 10 minutes, and it 
was concentrated with a rotary evaporator. To remove remained excess dimethylamine, the residue 
was re-dissolved in dichloromethane and re-evaporated in three times. The obtained slightly pink-
orange solid was purified by column chromatography (silica gel, 1:2 of ethyl acetate/hexane). The 
product was obtained as a white solid (294 mg, 1.11 mmol, 88.5 %)  
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TLC Rf = 0.38 (silica, 2:1, hexane/ethyl acetate) 
1H NMR (400 MHz, Chloroform-d) δ 8.97 (d, J = 8.7 Hz, 1H), 8.09 (d, J = 8.3 Hz, 1H), 7.47 (d, J 
= 8.7 Hz, 1H), 7.18 (d, J = 8.2 Hz, 1H), 2.76 (s, NCCH3, 3H), 2.75 (s, N(CH3)2, 6H) 
 
8-tert-butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfamoyl-2-methylquinoline (4) 
5-(N,N-dimethyl)sulfamoyl-8-hydroxy-2methylquinoline (3, 540 mg, 2.03 mmol) and imidazole 
(150 mg, 2.2mmol) were dissolved in dry DMF (3 mL). Tert-butyldiphenylsilyl chloride 
(TBDPSiCl, purchased from Alfa Aesar, 567 μL, 2.2 mmol) was added under nitrogen and stirred 
for 2 hours at room temperature. The solution was diluted with ethyl acetate (250 mL), washed 
with saturated ammonium chloride solution (50 mL) and brine (50mL x2), dried over MgSO4 and 
evaporated under low pressure. The crude solid was purified by silica gel column chromatography 
(1:9 of ethyl acetate / hexane). (1.01g, 99%) 
TLC Rf = 0.10 (silica, 9:1, hexane/ethyl acetate), Rf = 0.32 (silica, 4:1, hexane/ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 8.79 (d, J = 8.9Hz, 1H), 7.96 (d, J = 8.3 Hz. 1H), 7.74 (d, J = 6.6 
Hz, 4H), 7.34 (t, J = 7.2 Hz, 2H), 7.30 – 7.25 (m, 4H), 7.17 (d, J = 8.9 Hz, 1H), 7.14 (d, J = 8.3 Hz, 
1H) 2.71 (s, 6H), 2.18 (s, 3H), 1.16 (s, 9H) 
 
8-tert-butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfamoyl-2-formylquinoline (5) 
8-tert-butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfamoyl-2-methylquinoline (4, 162.63 mg, 0.322 
mmol) was added to a dray flask with dry 1,4-dioxane and molecular sieves under nitrogen. 
Selenium dioxide was added and the reaction was stirred at 95 OC for 17 hours. After the reaction 
was finished, the reaction mixture was cooled down to ambient temperature, filtered through celite 
to remove the black solid and molecular sieves, and eluted with dioxane. Dioxane was removed by 
rotary evaporation and the remained yellowish oil was re-dissolved in ethyl acetate (200 mL), 
washed with brine (20 mL), water (20 mL), saturated potassium carbonate solution (20 mL) and 
dried over MgSO4. The product solution was evaporated to give a crude product as a sticky yellow 
oil, which was used in the next step without further purification. (115 mg (69%) of pure product in 
the mixture evaluated by NMR integration)  
TLF Rf = 0.50 (silica, 2:1, hexane/ethyl acetate) 
1H NMR (400 mHz, CDCl3) δ 9.58 (s, CHO, 1H) 9.08 (d, J = 9 Hz, quinolone CH, 1H), 8.14 (d, 
J = 8.5 Hz, quinolone CH, 1H), 7.95 (d, J = 9 Hz, quinolone CH, 1H), 7.80-7.20 (m, diphenyl, 
10H), 7.18 (d, J = 8.5 Hz, quinolone CH, 1H), 2.74 (s, 2NCH3, 6H), 1.21 (s, tert-butyl, 9H)  
 
8-tert-butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfamoyl-2-(hydroxymethyl)quinoline (6) 
Sodium borohydride (12 mg, 0.317 mmol, purchased from Junsei) was dissolved in absolute 
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ethanol and cooled to 0 OC. Crude 8-tert-butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfamoyl-2-
formylquinoline (5, 0.322 mmol) was dissolved in dry dichloromethane and added dropwise to the 
cooled sodium borohydride solution. The reaction mixture was stirred for 15 minutes. Then the 
reaction solution was diluted with diethyl ether (200 mL), washed with saturated ammonium 
chloride (40 mL), water (40 mL x2), and brine (40 mL) and dried over MgSO4. The solvent was 
removed by rotary evaporation to yield a pale yellow sticky solid. The product was purified by 
silica gel column chromatography (2:1 of hexane and ethyl acetate). (88%) 
TLC Rf = 0.3 (2:1, hexane/ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 9.00 (d, J = 8,9 Hz, 1H), 7.97 (d, J = 8,3 Hz, 1H), 7.87-7.64 (m, 
4H), 7.50-7.28 (m, 6CH in diphenyl + 1CH in quinolone, 7H), 7.09 (d, J = 8.3 Hz, 1H), 4.63 (s, 
CH2OH, 2H), 2.71 (s, N(CH3)2, 6H), 1.19 (s, tert-butyl, 9H) 
 
2-bromomethyl-8-tert-butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfoamoylquinoline (Sox-Br, 
7) 
8-tert-butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfamoyl-2-(hydroxymethyl)quinolone (6, 100mg, 
0.192 mmol) was dried over P2O5 for 15 hours in a desiccator and dissolved in 1 mL of dry 
dichloromethane under nitrogen. The solution was cooled to 0 OC. N-bromosuccinimide (NBS) and 
triphenylphosphine were pre-mixed in dichloromethane and added into the cooled solution. The 
reaction solution was stirred for 4 hours at 0 OC. The reaction mixture was diluted with 1200 mL 
of diethyl ether, washed with water (150 mL) and brine (100 mL) and dried over MgSO4. The 
solvent was evaporated and the residue was purified by column chromatography (florisil, 100-200 
mesh, 1:9 of ethyl acetate/hexane). (55.9 mg, 50%) 
TLC Rf = 0.7 (2:1, hexane/ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 8.93 (d, J = 8,9 Hz, 1H), 8.02 (d, J = 8,3 Hz, 1H), 7.73 (dd, J = 8.0, 
1.4 Hz, 4H), 7.51 (d, J = 9.0 Hz, 1H), 7.40-7.21 (m, 6H), 7.15 (d, J = 8.3 Hz, 1H), 4.12 (s, CH2Br, 
2H), 2.72 (s, N(CH3)2, 6H), 1.17 (s, tert-butyl, 9H) 
13C NMR (101 MHz, CDCl3) δ 157.15, 155.42, 140.29, 134.93, 134.59, 133.37, 132.42, 129.65, 
127.58, 125.36, 123.81, 122.72, 115.75, 37.33, 32.71, 26.58, 20.17 
 
3-(tritylthio)propionic acid (trt-MPA, 8) 
In an air-dried flask, 3-mercaptopropionic acid (1mL, 11 mmol, purchased from Alfa Aesar) was 
dissolved in 20 mL of dichloromethane. Trityl chloride (3.14 g, 11 mmol) dissolved in 
tetrahydrofuran was slowly added into the reaction mixture at room temperature. After 15 minutes, 
a white solid became formed and the reaction mixture was stirred for 14 hours at room temperature. 
When the reaction was finished, the reaction mixture was filtered and washed with 
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dichloromethane three times. The filtered white solid gave desired product (3.73 g, 95%). 
1H NMR (400 MHz, CDCl3) δ 7.42 (dt, J = 8.7 Hz, 5H), 7.32 – 7.17 (m, 10H), 2.46 (t, J = 7.3 Hz, 
2H), 2.2.4 (t, J = 7.3 Hz, 2H) 
 
N-(2-(1H-imidazol-5-yl)ethyl)-3-(tritylthio)propanamide (trt-MPA-histamine, 9) 
3-(tritylthio)propionic acid (8, 380 mg, 1.1 mmol), N,N’-dicyclohexylcarbodiimide (DCC) and 
triethylamine were dissolved in 15 mL of N,N-dimethylformamide. Histamine dihydrochloride 
(200 mg, 1.1 mmol) were added and the reaction solution was stirred overnight at 40 OC. The 
reaction mixture was filtered, evaporated, extracted by dichloromethane and dried over MgSO4. 
The organic layer was evaporated and the residue was purified by silica gel column chromatography. 
(10:1 of ethyl acetate/Methanol) (337 mg, 70%). 
TLC Rf = 0.2 (10:1, ethyl acetate/methanol) 
1H NMR (400 MHz, Chloroform-d) δ 7.39 (d, J = 7.4 Hz, 5H in trityl group + 1H in imidazole 
group, 6H), 7.32 – 7.18 (m, trityl group, 10H), 6.75 (s, imidazole, 1H), 5.99 (s, CONH, 1H), 3.46 
(q, J = 6.1 Hz, CONHCH2, 2H), 2.77 (t, J = 6.3 Hz, CONHCH2CH2, 2H), 2.52 (t, J = 7.2 Hz, 
CH2CO, 2H), 1.93 (t, J = 7.2 Hz, trt-SCH2, 2H). 
13C NMR (101 MHz, Chloroform-d) δ 171.13, 144.62, 134.60, 129.57, 127.94, 126.73, 109.99, 
77.20, 66.79, 39.23, 25.63, 27.91, 26.71 
 
N-(2-(1H-imidazol-5-yl)ethyl)-3-mercaptopropanamide (MPA-histamine, 10) 
To a solution of N-(2-(1H-imidazol-5-yl)ethyl)-3-(tritylthio)propanamide (9, 110 mg, 0.250 mmol) 
in 10 mL of dichloromethane was added triethylsilane (TES, purchased from Alfa Aesar, 60 μL, 
0.38 mL) followed by trifluoroacetic acid (5 mL). The initially developed yellow color disappeared 
within a few seconds and the colorless reaction mixture was stirred at r.t for 2 hours. The volatiles 
were evaporated in vacuo and the residue was washed with hexane. Hexane was removed by 
suction carefully and the product was yellow-like liquid not mixed with hexane and heavier than 
hexane. (39.7 mg, 80%) 
TLC Rf = 0.2 (5:1, ethyl acetate/methanol) 
1H NMR (400 MHz, Methanol-d4) δ 9.77 (s, imidazole, 1H), 8.85 (s, CONH, 1H), 8.21 (s, 
imidazole, 1H), 4.14 (q, J = 6.5 Hz, CONHCH2, 2H), 3.57 (t, J = 6.8 Hz, CONHCH2CH2, 2H), 
3.41 (q, J = 7.2 Hz, HSCH2, 2H), 3.14 (t, J = 6.9 Hz, HSCH2CH2, 2H), 3.02 (td, J = 8.0, 1.7 Hz, 
SH, 1H). 
 
N-(2-(1H-imidazol-5-yl)ethyl)-3-(((8-hydroxy-5-(N,N-dimethylsulfamoyl)quinolin-2-yl)-
methyl)thio)propanamide (12) 
37 
 
N-(2-(1H-imidazol-5-yl)ethyl)-3-mercaptopropanamide (10, 20 mg, 0.1 mmol) was well-dried and 
dissolved in N,N-dimethylformamide (DMF, 2 mL). 1,1,3,3-Tetramethylguanidine (TMG) was 
added into the solution of 10, and Sox-Br (7, 30 mg, 0.05 mmol) was subsequently added and 
reacted for 1 hour at room temperature. The reaction solution was evaporated under low pressure, 
and product was extracted by ethyl acetate and washed with distilled water. The collected organic 
layer was dried over MgSO4 and solvent was evaporated. The product was purified by HPLC. (7 
mg, 30%) 
HPLC: 100% solvent A (clean H2O with 0.1% TFA) to 30% solvent A and 70% solvent B (9:1 of 
MeCN and H2O with 0.1% TFA) in 15 min., TR=13.1 min.  
1H NMR (400 MHz, Deuterium Oxide) δ 9.03 (d, J = 9.0 Hz, quinoline, 1H), 8.41 (s, imidazole, 
1H), 8.04 (d, J = 8.4 Hz, quinoline, 1H), 7.78 (d, J = 9.1 Hz, quinoline, 1H), 7.21 (d, J = 8.4 Hz, 
quinoline, 1H), 7.05 (s, imidazole, 1H), 4.02 (s, quinoline-CH2S, 2H), 3.25 (t, J = 6.7 Hz, 
CONHCH2, 2H), 2.69 (t, J = 6.6 Hz, CONHCH2CH2, 2H), 2.65-2.61 (m, CH2CO + N(CH3)2, 6H), 
2.33 (t, J = 6.7 Hz, SCH2CH2CO, 2H). 
13C NMR (101 MHz, D2O) δ 174.05, 162.77, 158.17, 146.56, 137.47, 133.57, 132.94, 130.57, 
124.81, 124.30, 120.54, 116.09, 111.39, 37.74, 36.74, 35.57, 35.14, 27.05, 23.93. 
 
Boc-glycine-OH (14) 
Boc2O (1.53 mL, 7 mmol) was added dropwise to L-glycine (3 g, 40 mmol) and 1 N NaOH (6 mL) 
at 0 OC for 30 minutes with stirring. Thereafter, temperature was raised up to 35 OC and the reaction 
solution was stirred for 2.5 hours. The reaction mixture was poured into hexane and the product 
was extracted by aqueous layer (25 mL of H2O x2, and 25 mL of Na2CO3 solution x2). The collected 
aqueous layer was adjusted into pH 1 using KHSO4. Product was extracted by ethyl acetate (25 mL 
x2) from the aqueous solution. The collected organic layer was dried over Na2SO4 and the solvent 
was removed by rotary evaporator to leave product. (5.3 g, 30 mmol, 75%) 
TLC Rf = 0.5 (65:24:4 of Chloroform/methanol/water) 
1H NMR (400 MHz, Chloroform-d) δ 9.50 (bs, COOH,1 H), 6.72 (bs, NH, 1H), 5.09 (bs, NH, 1H), 
3.98 (s, C*H2, 2H),1.46 (s, Boc, 9H)  
 
N-(2-(1H-imidazol-5-yl)ethyl)-2-(Boc)aminoacetamide (Boc-Gly-histaime, 15) 
Boc-Glycine was dissolved in DMF and triethylamine (1.9 g, 18.8 mmol) and HBTU (2.16 g, 5.70 
mmol). A few minutes later, histamine dihydrochloride (1.15 g, 6.267 mmol) was added into the 
mixture and stirred at room temperature for 1.5 hours. DMF was removed by rotary evaporator and 
the residue was diluted in ethyl acetate, washed with water and brine, and dried over Na2SO4. 
Solvent was removed and the product was purified by silica gel column chromatography (5:1 of 
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CHCl3/MeOH). (1.223 g, 4.558 mmol, 80%). 
1H NMR (400 MHz, D2O) δ 7.56 (s, imidazole, 1H), 6.79 (s, imidazole, 1H) 3.56 (s, C*H2, 2H), 
3.33 (t, J = 6.6 Hz, 2H), 2.66 (t, J = 6.4 Hz, 2H), 1.29 (s, Boc, 9H) 
 
N-(2-(1H-imidazol-5-yl)ethyl)-2-aminoacetamide (Gly-histamine, 16) 
Boc-Gly-Histamine (15) was dissolved in DCM and TES was added. Trifluoroacetic acid (TFA) 
was added and stirred for 10 minutes. Solvent was removed and ether was added. Precipitated solid 
was washed by ether three times. 
1H NMR (400 MHz, Deuterium Oxide) δ 8.47 (s, imidazole, 1H), 7.15 (s, imidazole, 1H), 3.64 (s, 
C*H2, 2H), 3.43 (t, J = 6.7 Hz, 2H), 2.84 (t, J = 6.8 Hz, 2H). 
 
Glycine-methyl ester (Gly-CH3, 27) 
4.354 mL of thionyl chloride (60 mmol) was added dropwise into 60 mL of ice-cold MeOH with 
stirring. 3 g of glycine (40 mmol) was added and stirred at room temperature for 4 hours. Solvent 
was removed by rotary evaporation. The residue was re-dissolved in MeOH and re-evaporated, 
repeating three times. It was dissolved in ether and evaporated another three times. The product 
was recrystallized in 1:9 of MeOH/ether. 4.3885 g of product (87%) was obtained as a white solid. 
1H NMR (400 MHz, Deuterium Oxide) δ 3.80 (s, 2H), 3.71 (s, 3H) 
 
Trt-MPA-Gly-CH3 (28) 
3-(tritylthio)propionic acid (8, 293 mg, 0.84 mmol), DIPEA (103.4 mg, 0.8 mmol) and HBTU 
(303.4 mg, 0.8 mmol) were dissolved in DMF. A couple of minutes later, glycine-methyl ester (27, 
100 mg, 1.1 mmol) was added and stirred at room temperature for 1.5 hours. After reaction was 
finished, solvent was evaporated and the residue was diluted with DCM, washed with water and 
brine, and dried over MgSO4. Dried organic layer was evaporated and product was purified by 
silica gel column chromatography (25:1 of DCM/MeOH). Product was 300 mg (0.72 mmol, 90%). 
1H NMR (400 MHz, Chloroform-d) δ 7.42 (d, J = 7.4 Hz, 6H), 7.34 – 7.16 (m, 9H), 6.20 (bs, 
CONH, 1H) 3.93 (d, J = 5.2 Hz, 2H), 3.69 (s, CH3COO, 3H), 2.78 (s, CONHCH2, 2H), 2.50 (t, J 
= 7.4 Hz, 2H), 2.06 (t, J = 7.4 Hz, 2H). 
13C NMR (101 MHz, Chloroform-d) δ 171.18, 170.28, 162.54, 144.65, 129.57, 127.93, 126.68, 
66.80, 52.26, 41.18, 38.60, 36.46, 35.12, 31.41, 27.46 
 
Trt-MPA-Gly-OH (29) 
800 mg of trt-MPA-Gly-Me (28, 800 mg, 1.91 mmol) was dissolved in 5 mL of methanol, and 13 
mL of 1N sodium hydroxide solution (13 mmol) was added with stirring at room temperature for 
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30 minutes. Thereafter, it was titrated into neutral pH using hydrochloric acid, and solvent was 
removed by rotary evaporator. The residue was re-dissolved in water and pH was set to 3 with 
hydrochloric acid. The product was extracted with ethyl acetate, dried over Na2SO4, and evaporated. 
(688 mg, 1.70 mmol, 89%) 
1H NMR (400 MHz, Chloroform-d) δ 7.42 (d, J = 8.1 Hz, 6H), 7.32 – 7.13 (m, 9H), 5.98 (bs, NH, 
1H) 3.97 (t, 2H), 2.51 (td, J = 7.3, 1.5 Hz, 2H), 2.05 (t, 2H). 
 
Trt-MPA-Gly-histamine (17) 
328 mg of trt-MPA-Gly-OH (29, 327.6 mg, 0.809 mmol) was dissolved in 1 mL of DMF, and 0.706 
mL of DIPEA (4.04 mmol) and 304 mg of HBTU (0.801 mmol) were added. A couple of minutes 
later, 156 mg of histamine dihydrochlorde (0.850 mmol) was added and stirred at room temperature 
for 2 hours. Solvent was removed by rotary evaporation. The residue was diluted into ethyl acetate, 
washed with water, dried over Na2SO4, evaporated. The product was purified by silica gel column 
chromatography (5:1 of CHCl3/MeOH). 
1H NMR (400 MHz, Methanol-d4) δ 7.59 (s, 1H), 7.43 – 7.17 (m, 15H), 6.82 (s, 1H), 3.76 (s, 2H), 
3.38 (t, J = 7.1 Hz, 2H), 2.73 (t, J = 7.1 Hz, 2H), 2.45 (t, J = 7.3 Hz, 2H), 2.27 (t, J = 7.3 Hz, 2H). 
 
MPA-Gly-histamine (18) 
226 mg of trt-MPA-Gly-histamine (0.45 mmol) was dissolved in 4 mL of dichloromethane, and 
TES (261 mg, 2.25 mmol) and 1 mL of TFA were added, with stirring at room temperature for 1 
minute. Solvent was removed by rotary evaporator, and residue was washed with hexane. 
1H NMR (400 MHz, Methanol-d4) δ 8.77 (s, 1H), 7.34 (s, 1H), 3.79 (s, 2H), 3.50 (t, J = 6.5 Hz, 
2H), 2.92 (t, J = 6.4 Hz, 2H), 2.76 (t, J = 6.8 Hz, 2H), 2.57 (t, J = 6.8 Hz, 2H). 
 
Sox-MPA-Gly-histamine (23) 
1H NMR (400 MHz, Deuterium Oxide) δ 8.90 (d, J = 9.0 Hz, 1H), 8.35 (s, 1H), 7.99 (d, J = 8.4 Hz, 
1H), 7.70 (d, J = 9.0 Hz, 1H), 7.14 (d, J = 8.4 Hz, 1H), 6.90 (s, 1H), 4.01 (s, 1H), 3.60 (s, 2H), 3.19 
(t, J = 6.6 Hz, 2H), 2.72 (t, J = 6.7 Hz, 2H), 2.60 (s, 8H), 2.46 (t, J = 6.7 Hz, 2H). 
13C NMR (101 MHz, Chloroform-d) δ 174.56, 171.23, 157.53, 153.84, 140.84, 134.43, 132.87, 
132.22, 130.41, 125.22, 124.69, 120.92, 116.02, 112.88, 42.40, 37.82, 36.66, 34.77, 27.03, 23.84 
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2.5 Experimental Data 
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Table 2-1. Numerical data of Figure 2-8. Fluorescence assay of model kinase sensor; 
1) Distilled water (control); 2) 1 mM sensor molecule; 
 3) 1mM sensor molecule and 10 mM MgCl2; 4) 1mM sensor molecule and 100 mM PPA;  
5) 1mM sensor molecule, 100 mM PPA and 10mM MgCl2. 
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Table 2-2. Numerical data of Figure 2-9.  
Fluorescence change by sensor molecule concentration 
 
 
Table 2-3. Numerical data of Figure 2-10. The fluorescence change in dependence of magnesium ion.  
 
 
0.1 mM Sensor 
0.1 mM Sensor 
+ 10 mM PPA 
0.1 mM Sensor 
+ 10 mM MgCl2 
0.1 mM Sensor + 10 mM PPA 
+ 10 mM MgCl2 
3347 3639 8804 22070 
3367 3122 8594 18156 
3357 3380.5 8699 20113 
Table 2-4. Numerical data of Figure 2-11. Phosphorylation and fluorescence of the 100 µM 
sensor molecule with 10 mM MgCl2. pH 7.5 100 mM phosphate buffer 
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Chapter 3. Proteomic Labeling Strategy through Desthiobiotin with  
Conjugation of Isotope-Labeled Tyramine using APEX System 
 
3.1 Introduction 
 
To understand the function of a protein, it is crucial to know its intracellular localization. The 
conventional method to identify proteins in certain organelles or compartments of cells is the 
fractionation of the organelle from cells, followed by mass spectrometry (MS)-based proteomics1). 
Using this technique, lots of proteins could be detected, although the limited specificity and loss of 
materials during the fractionation were limitation. Also, it could not be applied into live cells.  
To overcome these problems, localized protein tagging strategies have been used recently. For 
example, green fluorescent proteins (GFP) has been widely used for target protein imaging. GFP 
is genetically fused to the target protein and visualized. A problem of GFP is that it is quite large 
and it may affect the localization of small proteins. And it is tedious to carry out the genetic 
manipulation one by one. 
Biotin is also a very useful tag. It has a specific strong interaction with streptavidin, and it is 
possible to enrich biotin-tagged proteins using streptavidin-bead or visualized them with 
streptavidin-fluorophore in imaging system. Biotin-tagging in live cells has been successfully 
achieved using genetically encoded labeling enzymes which tag its neighboring proteins, but not 
too distant proteins preserving spatial relationships. Promiscuous biotin ligases2-4), activate biotin 
into biotin-adenylate ester, but it is a relatively long-lasting intermediate (a half-life of minutes) 
and low-specific spatial labeling in wide region.  
    Recently, an engineered ascorbate peroxidase (APEX)5,6), which is active in cell and oxidizes 
various phenol derivatives to phenoxy radicals has been utilized. The radicals are short-lived (1< 
ms) and have a small labeling region7-9). Also, radicals can make covalent bonds with amino acids 
including Tyr, His and Cys10-13). Thus, biotin labeling strategy has been developed, in which a 
biotin-labeled phenol derivative is tagged to the proteome of interest through radical reaction by 
genetically encoded APEX. However, it was discovered that thioether of biotin was oxidized into 
sulfoxide group during the radical reaction by APEX and it complicated the MS analyses14,15).  
    To address this, desthiobiotin was chosen to replace biotin; desthiobiotin is not oxidized 
during the radical reaction and it also had a strong affinity for streptavidin (Kd = 10-11M)16). It was 
revealed that desthiobiotin performed better than biotin17), and we decided to apply desthiobiotin 
in this approach. In addition, non-radioactive stable isotopes were incorporated in desthiobiotin-
phenol derivatives to apply in multiplex MS analyses instead of SILAC analyses. 
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3.2 Design of Isotope-labeled Desthiobiotinyl Tyramide 
 
To prepare desthiobiotin-phenol derivative, the tagged substrates for APEX, desthiobiotin was 
previously coupled with tyramine to give desthiobiotinyl tyramide (DBT). This time, it was 
necessary to prepare tyramine containing non-radioactive stable isotopes, which are 13-carbons 
and 15-nitrogens. By controlling the number of isotopes, we designed four kinds of DBTs with 
mass difference of three daltons. Its different molecular weight of tags will make it possible to 
distinguish target proteins in a same sample. 
 
 
Scheme 3-1. Synthesis of desthiobiotinyl tyramide 
 
 
 
Figure 3-1. Isotope-labeled desthiobiotinyl tyramide tags 
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3.3 Results and Discussion 
 
 
Scheme 3-2. Tyrosine decarboxylation 
 
Isotope-labeled tyramines were prepared by decarboxylation of commercial isotope-labeled 
tyrosine by enzymatic reaction of tyrosine decarboxylase18,19). Pyridoxal-5-phosphate was used as 
a cofactor for tyrosine decarboxylase. After reaction was finished, the reaction solution was 
removed by rotary evaporator and the residue was re-dissolved in water and passed through cation 
exchange column. As tyramine contained primary amine and was captured by column, it was eluted 
by 1 mM HCl solution, to give tyramine HCl salt after lyophilization.  
    Since the product could contain other inorganic salts, the product was exactly quantified using 
NMR comparing integration values with 1M 1,4-dioxane as internal standard. Tyramine and 
dioxane peaks were evaluated with their integration values and compared the ratio. 1,4-Dioxane 
had a single peak (eight hydrogens) in NMR and it was assigned to 8.00 integration value. The 
tyramine peak having one proton was 0.22 integration value, which means tyramine’s 
concentration was 0.22 M in NMR sample. Since we know the concentration of added dioxane, we 
could calculate the amount of tyramine. Three kinds of Isotope-containing tyrosine were purchased 
and converted to isotope-containing tyramines as shown below. 
 
 
 
Figure 3-2. Tyramine Quantification using NMR Integration 
P1 
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Three kinds of Isotope-containing tyrosine were purchased and converted to isotope-
containing tyramines which we wanted. 
 
 
Scheme 3-3. Isotope-labeled tyrosine 
 
 
 
Scheme 3-4. Carboxylic acid activation via NHS ester 
 
Synthesis of d-desthiobiotin-NHS ester was referred to the synthesis of biotin-NHS ester using 
DCC as the coupling agent. In case of biotin-NHS ester, it was not soluble in isopropanol whereas 
other compounds such as DCC, DCU, NHS (unreacted and remained), TEA (base) and DMF 
solvent were dissolved in isopropanol. So biotin-NHS ester was easily purified by precipitation in 
isopropanol. However, desthiobiotin-NHS ester was also soluble in isopropanol and another 
method was required. 
   When the reaction was finished, the precipitated solid (DCU) was removed by filtration and 
the solvent was evaporated. The residue was dissolved in ethyl acetate and worked up using ethyl 
acetate and NH4Cl acidic solution. As NHS-activated ester is stable in mild acid, d-desthiobiotin-
NHS ester was remaining in the organic phase and other mixtures were extracted into the aqueous 
phase. The organic layer was collected and evaporated to leave white powder. d-Desthiobiotin-
NHS ester was obtained with good purity and good yield. 
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Scheme 3-5. Synthesis of desthiobiotinyl tyramide 
 
As a test, non-labeled was reacted with d-desthiobiotin-NHS ester in a mixture of methanol 
and water. Reaction was monitored by TLC, and when the reaction was finished, solvent was 
removed by rotary evaporation. The product was easily separated from the reaction mixture using 
HPLC. (C18-column, 100% water to 75% water and 25% acetonitrile in 5 min, and 75% water and 
25% acetonitrile to 60% water and 40% acetonitrile in 40 min. All solvent contained 0.1% TFA.) 
Isotope-labeled tyramines were also conjugated with desthiobiotin-NHS ester to produce three 
kinds of isotope-labeled DBT products. 
 
 
Scheme 3-6. Isotope-labeled desthiobiotinyl tyramide 
 
 
3.4 Conclusion 
 
APEX is a good engineered enzyme and applicable in biological experiments. A series of 
isotope-labeled tyrosine were converted to tyramine, and the subsequent desthiobiotin conjugation 
were successful. Desthiobiotin-tyramide tags were appropriate substrates for APEX system. In MS-
based proteomics, their small difference of molecular weight can be distinguished, so isotope-
labeled tags will be working effectively, since their chemical and physical properties are identical, 
but definitely identified by MS analysis.  
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3.5 Methods and Experimental Data 
 
Synthesis of [13C8, 15N]tyramine (P1).  
The protocol for decarboxylation of d4-tyrosine as described by Ntai et al18) was followed with a 
few modifications. [13C9, 15N]tyrosine (100 mg) was dissolved in 100 mL H2O by microwave 
heating with little boiling until tyrosine was dissolved at all. The tyrosine solution was cooled to 
room temperature and a suspension of enzyme tyrosine decarboxylase from Streptococcus faecalis 
(2 mg, 0.05 unit/mg) and pyridoxal-5-phosphate (7 mg) in acetate buffer (4 mL, 0.1 M, pH 5.5) 
was added. The mixture was incubated at 37 oC for 6 hours with stirring. The reaction was stopped 
by heating the mixture to boiling. The reaction mixture was concentrated in vacuo and passed 
through Dowex 50WX cation exchange (hydrogen form) resin. The tyramine product was eluted 
from the resin with approximately 50 mL of 1 mM HCl and the solvent was evaporated to give 
[13C8, 15N]tyramine as a tan powder (74 mg, 97% yield).  
TLC Rf = 0.5 (Methanol with 5% v/v NH4OH solution) 
1H NMR (400 MHz, Deuterium Oxide) δ 7.09 (dd, J = 153.6, 8.4 Hz, ring 213CH, 2H), 6.77 (dd, J 
= 158.0, 6.3 Hz, ring 213CH, 2H), 3.12 (d, J = 134.0 Hz, 13CH215NH2, 2H), 2.79 (d, J = 120.9 Hz, 
13C13CH2, 2H) ppm.  
13C NMR (101 MHz, Deuterium Oxide) δ 154.44 (td, J = 65.3, 8.7 Hz), 130.22 (t, J = 54.4 Hz), 
128.40 (m), 115.67 (td, J = 64.0, 62.8, 3.6 Hz), 40.68 (dd, J = 35.0, 4.0 Hz), 31.81 (td, J = 39.3, 
4.4 Hz) ppm.  
HRMS (ESI) Calcd. for 13C8H1215NO+; 147.1152 m/z (M+H), Observed; 147.1151 m/z (M+H) 
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Synthesis of [ring-13C6]tyramine (P2).  
The protocol was identical with the synthesis of [13C8, 15N]tyramine (P1), except for the use of 
[ring-13C6]tyrosine as the starting material.  
1H NMR (400 MHz, Deuterium Oxide) δ 7.08 (dd, J = 156.0, 6.6 Hz, ring 213CH, 2H), 6.77 (dd, J 
= 157.4, 7.0 Hz, ring 213CH, 2H), 3.11 (s, CH2NH2, 2H), 2.80 (d, J = 7.3 Hz, 13CCH2, 2H) ppm. 
13C NMR (101 MHz, Deuterium Oxide) δ 154.44 (td, J = 65.4, 8.7 Hz), 130.24 (t, J = 52.2 Hz), 
128.36 (dd, J = 65.4, 62.5 Hz), 115.65 (m), 40.70, 31.80 (d, J = 43.6 Hz) ppm.  
HRMS (ESI) Calcd. for C213C6H12NO+; 144.1115 m/z (M+H), Observed; 144.1114 m/z (M+H) 
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Synthesis of [13C2, 15N]tyramine (P3). 
The protocol was identical with the synthesis of [13C8, 15N]tyramine (P1) except for the use of [13C2, 
15N]tyrosine as the starting material.  
1H NMR (400 MHz, Deuterium Oxide) δ 7.09 (dd, J = 8.3, 4.0 Hz, ring 2CH, 2H), 6.77 (dd, J = 
8.4 Hz, ring 2CH, 2H), 3.12 (dd, J = 130.8, 4.1 Hz, 13CH215NH2, 2H), 2.79 (dd, J = 121.9, 7.1 Hz, 
C13CH2, 2H) ppm.  
13C NMR (101 MHz, Deuterium Oxide) δ 154.46, 130.20, 128.33 (d, J = 46.3 Hz), 115.70, 40.64 
(dd, J = 34.9, 5.0 Hz), 31.79 (d, J = 34.9 Hz) ppm. 
HRMS (ESI) Calcd. for C613C2H1215NO+; 141.0951 m/z (M+H), Observed; 141.0950 m/z (M+H) 
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Synthesis of d-Desthiobiotinyl[13C8, 15N]tyramine (P4). 
The protocol was referred to the synthesis of d-biotinyl tramide21). [13C8, 15N]tyramine (190.8 mg, 
1.32 mmol) was dissolved in 5 mL of methanol/water (3:1). d-Desthiobiotinyl-NHS ester (P7, 
450.1 mg, 1.44 mmol) and triethylamine (209 μL, 1.44 mmol) were added to the tyramine solution. 
5 mL of methanol was added and the resulting solution was stirred at room temperature for 16 
hours. The reaction mixture was concentrated in vacuo and the residue was extracted by ethyl 
acetate (50 mL x 8 times) from water (50 mL). The collected organic phase was dried over 
magnesium sulfate, filtered, and concentrated in vacuo. The crude product was purified by reverse-
phase HPLC (C18 column, 10 mL/min, 15 to 35% acetonitrile/water over 40 min, retention time 10 
min). The product was lyophilized to yield white powder. (250 mg, 0.75 mmol, 57%) 
TLC Rf = 0.85 (3:1, ethyl acetate/methanol) 
HPLC method: 20-40B, 15 min. 100% solvent A to 20% solvent A and 80% solvent in 2 minutes, 
and subsequent to 60% solvent A and 40% solvent B. TR = 12.043 min. 
Solvent A: clean water with 0.1% TFA 
Solvent B: 9:1 of MeCN and water with 0.1% TFA 
1H NMR (400 MHz, Methanol-d4) δ 7.02 (dd, J = 154.3, 6.7 Hz, ring 213CH, 2H), 6.70 (d, J = 
158.6 Hz, ring 213CH, 2H), 3.81 (p, J = 6.5 Hz, CHCH3, 1H), 3.67 (q, J = 6.9 Hz, CHCH2CH2, 
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1H), 3.35 (d, J = 138.8 Hz, 15NH13CH2, 2H), 2.68 (d, J = 126.6 Hz, C13CH2, 2H), 2.14 (t, J = 7.3 
Hz, CH2CONH, 2H), 1.57 (t, J = 7.0 Hz, CHCH2, 2H), 1.49 – 1.28 (m, CCH2CH2CH2CH2, 6H), 
1.10 (d, J = 6.4 Hz, CHCH3, 3H) ppm.  
13C NMR (101 MHz, Methanol-d4) δ 174.65 (d, J = 14.9 Hz), 164.77, 155.45 (td, J = 66.6, 8.3 Hz), 
129.56 (ddd, J = 18.6, 12.2, 5.3Hz), 129.02 (m), 114.74 (ddd, J = 65.5 54.6, 11.8 Hz), 55.99, 51.29, 
40.67 (dd, J = 35.0, 10.0 Hz), 35.57 (d, J = 7.1 Hz), 34.23 (ddt, J = 44.1 35.1, 7.5 Hz), 29.28, 28.72, 
25.78, 25.47, 14.22 ppm.  
HRMS (ESI) Calcd. for C1013C8H27N215NO3; 343.2364 m/z (M+H), 365.2183 m/z (M+Na) 
Observed; 343.2362 m/z (M+H) 365.2180 m/z (M+Na).  
IR 3265.79, 2933.84, 1691.80, 1643.31, 1540.76, 1477.59, 1435.30, 1215.46  
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Synthesis of d-Desthiobiotinyl[ring-13C6]tyramine (P5).  
The protocol was identical with synthesis of Synthesis of d-Desthiobiotinyl[13C8, 15N]tyramine (P4). 
1H NMR (400 MHz, Methanol-d4) δ 7.02 (dt, J = 163.7, 8.7 Hz, ring 213CH, 2H), 6.70 (d, J = 158.7 
Hz, ring 213CH, 2H), 3.83 (p, J = 6.6 Hz, CHCH3, 1H), 3.68 (dt, J = 14.0, 6.9 Hz, CHCH2CH2, 
1H), 3.36 (t, J = 6.3 Hz, NHCH2, 2H), 2.69 (s, CCH2, 2H), 2.15 (t, J = 7.3 Hz, CH2CONH, 2H), 
1.58 (p, J = 7.1 Hz, CHCH2, 2H), 1.52 – 1.23 (m, CCH2CH2CH2CH2, 6H), 1.10 (d, J = 6.4 Hz, 
CHCH3, 3H)  
13C NMR (101 MHz, Methanol-d4) δ 174.76, 164.76, 155.47 (td, J = 67.7, 8.5 Hz), 129.59 (dt, J = 
12.7, 5.6 Hz), 129.13 (m), 114.75 (ddd, J = 62.6, 49.0, 11.1 Hz), 56.09, 51.40, 40.74, 35.57, 34.26 
(d, J = 29.1 Hz), 29.26, 28.73, 25.75, 25.50, 14.22.  
HRMS (ESI) Calcd for C1213C6H28N3O3+; 362.2146 m/z (M+H) Observed; 362.2145 m/z (M+H).  
IR 3277.00, 2936.69, 1691.29, 1647.66, 1543.74, 1477.65, 1438.09, 1216.10 
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Synthesis of d-Desthiobiotinyl[13C2, 15N]tyramine (P6).  
The protocol was identical with synthesis of Synthesis of d-Desthiobiotinyl[13C8, 15N]tyramine (P4).  
1H NMR (400 MHz, Methanol-d4) δ 7.02 (dd, J = 8.5, 3.9 Hz, ring 2CH, 2H), 6.70 (d, J = 8.5 Hz, 
ring 2CH, 2H) 3.81 (m, CHCH3, 1H), 3.68 (q, J = 7.4 Hz, CHCH2CH2, 1H), 3.35 (dtd, J = 139.0, 
7.1, 3.0 Hz, 15NH13CH2, 2H), 2.68 (dtdd, J = 127.4, 7.2, 5.1, 2.3 Hz, C13CH2, 2H), 2.14 (t, J = 7.1 
Hz, CH2CONH, 2H), 1.58 (p, J = 7.4 Hz, CHCH2, 2H), 1.50-1.27 (m, CCH2CH2CH2CH2, 6H), 
1.10 (d, J = 6. 5 Hz, CHCH3, 3H)  
13C NMR (101 MHz, Methanol-d4) δ 174.78, 164.49, 155.51, 129.79 (d, J = 44.9 Hz), 129.34, 
114.78 (d, J = 3.8 Hz), 56.05, 51.35, 40.69 (dd, J = 35.2, 9.9 Hz), 35.57 (d, J = 7.2 Hz), 34.22 (d, 
J = 35.2 Hz), 29.28, 28.73, 25.76, 25.49, 14.20 
HRMS (ESI) Calcd for C1613C2H28N215NO3+; 337.2163 m/z (M+H), C1613C2H27N215NO3Na+; 
359.1982 m/z (M+Na), Observed; 337.2161 m/z (M+H), 359.1982 m/z (M+Na) 
IR 3276.36, 2935.77, 1688.72, 1514.68, 1448.52, 1240.40, 1200.72 
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Synthesis of d-Desthiobiotinyl-NHS ester (P7).  
The protocol was referred to the synthesis of d-biotinyl-NHS ester3\20). d-Desthiobiotin (1.3 g, 6.07 
mmol) was dissolved in DMF (20 mL) and N,N’-dicyclohexylcarbodiimide (DCC, 1.37 g, 6.67 
mmol), N-hydroxysuccinimide (NHS; 0.91 g, 7.89 mmol) and triethylamine (1.3 mL, 9.10 mmol) 
were added. The mixture was stirred at room temperature for 24 h. The reaction product was filtered 
and concentrated. The obtained solid was extracted by ethyl acetate from ammonium chloride 
solution. The collected organic layer was evaporated and product was obtained as a white powder. 
Product was used in next step without further purification. (1.6 g, 5.14 mmol, 85 %) 
TLC Rf = 0.1 (4:1, ethyl acetate/MeOH) 
1H NMR (400 MHz, CDCl3) δ 5.27 (s, CONH, 1H), 4.86 (s, CONH, 1H), 3.86 (p, J = 6.6 Hz, 
CHCH3, 1H), 3.71 (td, J = 8.1, 3.9 Hz, CHCH2, 1H), 2.85 (s, 2NCOCH2, 4H), 2.63 (t, J = 7.2 Hz, 
CH2COO, 2H), 1.78 (p, J = 7.3 Hz, CHCH2, 1H), 1.58-1.27 (m, 6H), 1.13 (d, J = 6.5 Hz, CHCH3, 
3H).  
13C NMR (101 MHz, CDCl3) δ 127.87, 169.26, 168.60, 163.60, 55.93, 51.40, 29.50, 28.63, 25.89, 
25.62, 24.32, 15.77. 
HRMS (ESI) Calcd for C14H21N3O5Na +; 334.1373 m/z (M+Na) Observed; 334.1370 m/z (M+Na).  
IR 1735.32, 1699.90, 1206.26, 1068.07 
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